$AOMD

Fierman Michael purchased $291K of AOMD

Fierman Michael purchased 38,726 shares of Angel Oak Mortgage REIT, Inc. (AOMD) at $7.50 ($0.29M total) on 2026-09-25.

Original reporting
SEC EDGAR · Fierman Michael
Published Sep 28, 2026, 9:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 2:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AOMD
Bullish
medium confidence
Mentioned
$AOMD
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AOMDBullishLow
01

Why it matters

The disclosed insider purchase provides fresh data on insider sentiment, which can be factored into short‑term trading decisions.

02

Market read

New Form 4 filing; modest insider buying may slightly influence AOMD's stock perception.

03

What to watch

The purchase size is small relative to total shares outstanding; market may not react significantly.

Relevance 5/10Novelty 7/10Timing: after-market today

Background

Angel Oak Mortgage REIT (AOMD) is a mortgage REIT focused on residential mortgage-backed securities.

Company-level read

Ticker impact

$AOMDBullishMedium confidence
Context

Director Michael Fierman bought 38,726 shares for $291K, increasing his stake to 105,247 shares.

Expected impact

likely modest upward pressure as market prices in insider buying

Evidence & confidence

Form 4 filing is primary source; size is modest relative to market cap, but director ownership change is material for traders.

Market effects

Minimal impact on mortgage REIT sector; insider buying may be noted by sector analysts.

None

None

Counterpoint

Insider purchase could be a routine portfolio rebalancing, not a strong bullish signal.

Key entities

  • Angel Oak Mortgage REIT, Inc.

    Issuer of the Form 4 filing.

  • Michael Fierman

    Director and 10% owner of AOMD who made the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AOMDMed

Angel Oak Mortgage REIT, Inc. Reports Second Quarter 2026 Financial Results

Angel Oak Mortgage REIT, Inc. (AOMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Angel Oak Mortgage REIT, Inc. Reports Second Quarter 2026 Financial Results ATLANTA – August 4, 2026 -- Angel Oak Mortgage REIT, Inc. (NYSE: AOMR) (the “Company,” “we,” and “our”) , a leading real estate finance company focused on acquiring and investing in first and second lien

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).